期刊文献+

CDK13在耐药性癫痫患者脑组织中的表达

Expression of CDK13 mRNA in the brain tissue of patients with drug-resistant epilepsy
下载PDF
导出
摘要 目的:研究耐药性癫痫患者脑组织内依赖细胞周期的蛋白激酶13(Cell cycle-dependent protein kinase 13,CDK13)mRNA的表达。方法:在基因芯片扫描的基础上,运用逆转录-多聚酶链反应(Reverse transcription polymerase chain reaction,RT-PCR)技术检测CDK 13mRNA在难治性癫痢患者脑部的变化。结果:基因芯片扫描显示CDK13 mRNA在耐药性癫痫患者脑部比正常人表达上调2.159倍,RT-PCR检测同样显示CDK13 mRNA在耐药性癫痫患者脑部表达增强,信号明显增高,提示候选基因CDK-13 mRNA在耐药性癫痫患者脑组织中表达上调,RT-PCR与cDNA芯片结果一致。结论:虽然CDK13具体生物功能尚不明确,但我们认为CDK13可能作为重要的调节因子参与了神经元凋亡等分子事件。CDK13mRNA表达上调可能在耐药性癫痫发病机制中起一定作用。 Objective:To study the change of CDK13 mRNA expression in the brain tissue of patients with drug-resistant epilepsy so as to explore the possible mechanisms of the pathogenesis of refractory epilepsy.Methods: The microarray scanning and reverse transcription polymerase chain reaction(RT-PCR) were used to evaluate CDK-13mRNA expression in the brain tissue of 40 refractory epileptic patients and 8 normal controls.Results:As compared with the 8 normal controls,there appeared a significant increase in CDK13 mRNA expression in the patients with drug-resistant epilepsy,with the ratio of cy5/cy3 being 2.159 in microarray scanning(CDK13 mRNA expression in the patients with drug-resistant epilepsy was upregulated by 2.159 times compared with the normal controls.),and the results of RT-PCR were coincided well with those of the cDNA chip.Conclusion: Further study should be made to clarify the precise function of CDK13.CDK13 may take part in the molecular event in neuronal apoptosis as an important modulator.The up-regulation of CDK13 mRNA expression may play an important role in the epileptogenic mechanisms of drug-resistant epilepsy
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2011年第7期797-799,共3页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:81071039)
关键词 CDK13 耐药性癫痫 基因芯片 逆转录-多聚酶链反应 能量代谢 CDK13 drug-resistant epilepsy complementary DNA microarray(cDNA microarray) RT-PCR energy metabolism
  • 相关文献

参考文献7

二级参考文献48

  • 1王学嶂,沈鼎烈.卡马西平、苯妥英钠的耐受性研究[J].临床神经病学杂志,1993,6(4):226-228. 被引量:8
  • 2王学峰.丙戊酸镁的良性和不良耐受性[J].新药与临床,1993,12(5):289-290. 被引量:5
  • 3汪建华,王学峰,龚云,晏勇,栾国明,王玉平,李云林,张建国,卢涌,李红卫.耐药性癫癎患者术后脑组织中Tau蛋白的表达[J].中华神经科杂志,2005,38(9):543-546. 被引量:9
  • 4Lew J, Winkfein R J, Paudel H K, et al. Brain proline directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2 [J]. J Biol Chem, 1992,267 (36) : 25922-25926.
  • 5Meyerson M, Enders G H, Wu C L, et al. A family of human cdc2-related protein kinase [J]. EMBO J, 1992, 11 (8): 2909-2917.
  • 6Hahn C M, Kleinholz H, Koester M P, et al. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization[J].Neuroscience, 2005,134(2) :449-465.
  • 7Li-Huei Tsai, Ming-Sum Lee, Jonathan Cruz. CdkS, a therapeutic target for Alzheimer's disease [J]. Biochim Biophys Acta, 2004,1697 (1-2) : 137-142.
  • 8Hidetoshi Ino, Toshiharu I, Tanemichi C, et al. Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase,in the mature and developing mouse central and peripheral nervous systems [J]. Brain Res, 1994,661(1-2) :196-206.
  • 9Cicero S, Herrup K. Cyelin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation [J].J Neurosci, 2005,25 (42) : 9658-9668.
  • 10Patzke H, Tsai L H. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29 [J]. J Biol Chem, 2002,277 (10) : 8054-8060.

共引文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部